Group 5: Post-CME with Standard Patient Care for Vertigo

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Kaiser Permanente Southern California, Pasadena, CAVertigo+3 MoreStudy Developed Educational Materials for Patients - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial evaluates evidence-based practices for common causes of dizziness to improve care delivery in the ED.

Eligible Conditions
  • Vertigo
  • Vestibular Disorders
  • Dizziness
  • Benign Paroxysmal Positional Vertigo

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: Cumulative 4 weeks following index ED visit

Week 4
Dizziness Handicap Inventory
Day 1
Documentation of Dix-Hallpike Test/Canalith Repositioning Maneuver

Trial Safety

Safety Progress

1 of 3

Trial Design

6 Treatment Groups

Group 3: Pre-CME with Chart Review Only
1 of 6
Group 2: Pre-CME with Standard Patient Care
1 of 6
Group 5: Post-CME with Standard Patient Care
1 of 6
Group 4: Post-CME with Patient Education
1 of 6
Group 1: Pre-CME with Patient Education
1 of 6
Group 6: Post-CME with Chart Review Only
1 of 6

Active Control

Experimental Treatment

80000 Total Participants · 6 Treatment Groups

Primary Treatment: Group 5: Post-CME with Standard Patient Care · No Placebo Group · N/A

Group 5: Post-CME with Standard Patient Care
Behavioral
Experimental Group · 1 Intervention: CME Educational Intervention · Intervention Types: Behavioral
Group 4: Post-CME with Patient EducationExperimental Group · 2 Interventions: Study Developed Educational Materials for Patients, CME Educational Intervention · Intervention Types: Behavioral, Behavioral
Group 1: Pre-CME with Patient Education
Behavioral
Experimental Group · 1 Intervention: Study Developed Educational Materials for Patients · Intervention Types: Behavioral
Group 6: Post-CME with Chart Review Only
Behavioral
Experimental Group · 1 Intervention: CME Educational Intervention · Intervention Types: Behavioral
Group 3: Pre-CME with Chart Review OnlyNoIntervention Group · 1 Intervention: Group 3: Pre-CME with Chart Review Only · Intervention Types:
Group 2: Pre-CME with Standard Patient CareNoIntervention Group · 1 Intervention: Group 2: Pre-CME with Standard Patient Care · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: cumulative 4 weeks following index ed visit

Who is running the clinical trial?

Kaiser PermanenteOTHER
512 Previous Clinical Trials
22,168,410 Total Patients Enrolled
1 Trials studying Vertigo
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
292 Previous Clinical Trials
95,815 Total Patients Enrolled
4 Trials studying Vertigo
8,452 Patients Enrolled for Vertigo
Ohio State UniversityLead Sponsor
730 Previous Clinical Trials
389,523 Total Patients Enrolled
University of MichiganOTHER
1,647 Previous Clinical Trials
6,340,447 Total Patients Enrolled
1 Trials studying Vertigo
7,635 Patients Enrolled for Vertigo
Kevin Kerber, MDPrincipal InvestigatorOhio State University
Huong Nguyen, PhDPrincipal InvestigatorKaiser Permanente
Will Meurer, MDPrincipal InvestigatorUniversity of Michigan

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are 18 years old or older.
You have been diagnosed with dizziness or balance problems, as indicated by specific medical codes.
You were sent home from one of 14 specific hospitals in Southern California within the last two days after receiving emergency medical care.
You have been enrolled in a health plan for at least the past 31 days.
You must be able to speak either English or Spanish.

Frequently Asked Questions

Is enrollment currently available for this clinical trial?

"Affirmative. According to clinicaltrials.gov, this experiment is currently accepting applications from participants; it was first posted on November 11th 2022 and the last edit occurred December 1st 2022. 80,000 volunteers are needed across one site for successful completion of the trial." - Anonymous Online Contributor

Unverified Answer

What is the aggregate number of individuals taking part in this experiment?

"Affirmative, the trial is actively sourcing participants. This clinical investigation went up on 11/11/2022 and was most recently updated 12/1/2022. The study seeks 80000 individuals across a single site." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.